Quantum Corporation (Nasdaq: QMCO) ("Quantum" or the "Company"),
a leader in solutions for AI and unstructured data, announced today
financial results for its fiscal full year 2024 ended March 31,
2024.
Fiscal 2024 Financial Summary
- Revenue was $311.6 million
- GAAP gross profit was $124.9 million, or 40% of revenue
- GAAP net loss was $41.3 million, or ($0.43) per share
- Annual recurring revenue was $145 million
- Subscription ARR was up 33% year-over-year at $17.8
million
- Adjusted non-GAAP net loss was $27.5 million, or ($0.29) per
share
- Adjusted EBITDA was ($5.3) million
“Following the recent completion of our financial re-evaluation
process, we are pleased to be back discussing our operations and
financials, including results for fiscal 2024,” stated Jamie
Lerner, Chairman and CEO of Quantum. “Although this comprehensive
process was time-intensive, it demonstrates our commitment to the
highest standards of financial integrity and transparency. The
financial restatement adjustments made were all technical
accounting in nature and we found no evidence of intentional
misconduct.
“Our full year 2024 results reflect a significant reduction of
revenue from our largest hyperscale customer, which we had expected
would scale down over time but instead stopped placing orders at
the end of fiscal Q1 2024. While extremely disappointed with the
impact from significantly lower revenue year-over-year, we have
been proactively accelerating our business transformation. During
this time, our team continues to focus on improving the Company’s
capital structure as well as optimizing our overall business
operations.”
“These actions include improved focus and retooling of our sales
and product initiatives in strategic growth areas; accelerating
operational efficiencies and cost reductions to achieve $16 million
of total annualized savings; year-over-year gross margin
improvement of over 600 basis points; and strengthening our capital
structure through balance sheet optimization, sale of non-core
assets, and debt reduction. A recent example of these actions in
motion, subsequent to fiscal year-end, was completing a transaction
to reduce liabilities and carrying costs through the sale of
service inventory assets. Then using the proceeds to pay down
outstanding debt. Additionally, we have active efforts to
restructure and shift resources to leverage our international
footprint and to expand our channel partner network in Asia and
North America,” Mr. Lerner commented further.
Mr. Lerner continued, “Looking ahead, we remain committed to
getting back to profitability as well as stabilizing and improving
the performance of our legacy Automation and StorNext solutions.
Quantum remains dedicated to use cases for Media &
Entertainment, Life Sciences, Industrial Technology, and Federal
while improving our position to address the prevailing industry
trends around Artificial Intelligence across the multiple verticals
we serve. ActiveScale and Myriad will be the center of our growth
strategy by serving use cases that drive higher recurring revenue,
with improved margins, in faster growing market segments. Execution
of our strategy to advance our operating model, combined with
improving our capital structure, will drive step-change
improvements to Quantum in fiscal 2025.”
Fiscal 2024 vs. Prior Year
Revenue of $311.6 million for fiscal 2024 decreased 26.2% from
$422.1 million in the prior year, primarily reflecting lower
revenue contribution from hyperscale customers combined with lower
tape media and royalty business. Gross profit in fiscal 2024 was
$124.9 million, or 40.1% of revenue, compared to $143.3 million, or
33.9% of revenue, in the prior fiscal year.
Total GAAP operating expenses in fiscal 2024 were $153.8
million, or 49.3% of revenue, compared to $159.9 million, or 37.9%
of revenue, in the prior fiscal year. Selling, general and
administrative expenses were $112.4 million in fiscal year 2024,
compared to $113.8 million in the prior fiscal year. Research and
development expenses were $38.0 million in fiscal 2024, compared to
$44.6 million in fiscal 2023. Non-GAAP operating expenses in fiscal
2024 were $136.1 million, compared to $142.9 million in the prior
fiscal year.
GAAP net loss in fiscal 2024 was $41.3 million, or ($0.43) per
share basic and diluted, compared to a net loss of $18.4 million,
or ($0.20) per share basic and ($0.28) per share diluted, in the
prior fiscal year. Excluding the income statement impact of the
warrants, stock compensation, restructuring charges, and other
non-recurring costs, non-GAAP adjusted net loss in fiscal year was
$27.5 million, or ($0.29) per share basic and diluted, compared to
an adjusted net gain of $3.2 million, or $0.04 per share basic and
$0.03 per share diluted, in the prior year.
Adjusted EBITDA in fiscal 2024 was ($5.3) million, compared to
$21.1 million in fiscal year 2023.
For a reconciliation of GAAP to non-GAAP financial results,
please see the financial reconciliation tables below.
Liquidity and Debt (as of March 31, 2024)
- Cash, cash equivalents and restricted cash were $25.9 million,
compared to $26.2 million as of March 31, 2023.
- Total interest expense for the three- and twelve-month periods
were $4.1 million and $15.1 million, respectively, compared to $3.0
million and $10.6 million for the same periods a year ago.
- Outstanding term loan debt, excluding debt issuance costs, was
$87.9 million, compared to $74.7 million as of March 31, 2023.
Outstanding borrowings on revolving credit facility was $26.6
million, compared to $16.8 million as of March 31, 2023.
- Subsequent to quarter end, we paid down $12.3 million of term
loan debt through improved working capital by outsourcing our
service inventory logistics and management.
Guidance
For the fiscal first quarter of 2025, the Company expects the
following guidance:
- Revenues of $72.0 million, plus or minus $2.0 million
- Non-GAAP adjusted basic net loss per share of ($0.09), plus or
minus $0.02
- Adjusted EBITDA of approximately ($2.0) million
For fiscal year 2025, the Company expects the following
outlook:
- Revenues of $310 million, plus or minus $10.0 million
- Non-GAAP adjusted basic earnings per share of ($0.10), plus or
minus $0.05
- Adjusted EBITDA of $15.0 million, plus or minus $5.0
million
This assumes an effective annual tax rate of negative 14%;
non-GAAP adjusted net loss per share assumes an average basic share
count of approximately 96 million in the fiscal first quarter of
2025 and approximately 96.4 million for the fiscal year 2025.
Conference Call and Webcast
Management will host a live conference call today, June 17,
2024, at 5:00 p.m. ET (2:00 p.m. PT) to discuss these results. The
conference call will be accessible by dialing 866-424-3436 (U.S.
Toll-Free) or +1-201-689-8058 (International) and entering
conference ID 13747008. This conference call will be broadcast live
over the Internet with a slide presentation and can be accessed by
all interested parties on the investor relations section of the
Company's website at investors.quantum.com under the events and
presentations tab.
A telephone replay of the conference call will be available
approximately two hours after the conference call and will be
available through June 24, 2024. To access the replay dial
1-877-660-6853 and enter the conference ID 13747008 at the prompt.
International callers should dial +1-201-612-7415 and enter the
same conference ID. Following the conclusion of the live call, a
replay of the webcast will be available on the Company's website at
www.quantum.com for at least 90 days.
About Quantum
Quantum delivers end-to-end data management solutions designed
for the AI era. With over four decades of experience, our data
platform has allowed customers to extract the maximum value from
their unique, unstructured data. From high-performance ingest that
powers AI applications and demanding data-intensive workloads, to
massive, durable data lakes to fuel AI models, Quantum delivers the
most comprehensive and cost-efficient solutions. Leading
organizations in life sciences, government, media and
entertainment, research, and industrial technology trust Quantum
with their most valuable asset – their data. Quantum is listed on
Nasdaq (QMCO). For more information visit www.quantum.com.
Quantum and the Quantum logo are registered trademarks of
Quantum Corporation and its affiliates in the United States and/or
other countries. All other trademarks are the property of their
respective owners.
Forward-Looking Information
The results reported in this press release are preliminary and
unaudited, and are subject to change. As previously disclosed, the
Company is in the process of restating its previously issued
results for its (i) audited consolidated financial statements for
the fiscal years ended March 31, 2023 and March 31, 2022, (ii)
unaudited interim condensed consolidated financial statements for
each of the first three quarters in such years and (iii) unaudited
interim condensed consolidated financial statements for the fiscal
quarter ended June 30, 2023. The Company has not yet completed its
annual financial close process for the fiscal 2024 fourth quarter
and full year, and its independent auditors have not completed
their audit of the Company’s financial statements for the fiscal
2024 full year. In addition, the Company is in the process of
completing the financial close process for the Restatement, and its
independent auditors have not completed their audit and applicable
reviews of the Restatement. The financial results in this earnings
report does not present all necessary information for an
understanding of the Company’s results of operations for the fiscal
2024 fourth quarter and full year as well as the financial
statements that will be included in the Restatement. As the Company
completes its financial close process and finalizes its financial
statements for the fiscal 2024 fourth quarter and full year as well
as for the Restatement, and as its independent auditors complete
their audit of the Company’s financial statements for the fiscal
2024 full year and complete their applicable audit and reviews of
the Restatement, it is possible the Company may identify items that
require adjustments to the preliminary financial information set
forth in this earnings report, and those changes could be material.
The Company is in the final stages of confirming the revised
financial results to be reflected in the Restatement and expects to
file its current financial results, as well as its restated results
in a super Form 10-K. The Company does not intend to update such
financial information prior to the filing of its super Form
10-K.
The information provided in this press release may include
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934 (“Exchange Act”). These forward-looking statements are
largely based on our current expectations and projections about
future events and financial trends affecting our business. Such
forward-looking statements include, in particular, statements
related to future projections of our financial results, including
for the first fiscal quarter of 2025 and fiscal year 2025; our
focus and our strategy; expected benefits of our restructuring
plan, including annualized savings and the timing of payback; and
expectations with respect to revenue growth and EBITDA expansion in
fiscal year 2025.
These forward-looking statements may be identified by the use of
terms and phrases such as “anticipates”, “believes”, “can”,
“could”, “estimates”, “expects”, “forecasts”, “intends”, “may”,
“plans”, “projects”, “targets”, “will”, and similar expressions or
variations of these terms and similar phrases. Additionally,
statements concerning future matters and other statements regarding
matters that are not historical are forward-looking statements.
Investors are cautioned that these forward-looking statements
relate to future events or our future performance and are subject
to business, economic, and other risks and uncertainties, both
known and unknown, that may cause actual results, levels of
activity, performance or achievements to be materially different
from those expressed or implied by any forward-looking
statements.
These forward-looking statements involve risks and uncertainties
that could cause actual results to differ materially from those
projected, including without limitation, the following: risks
related to the need to address the many challenges facing our
business; the impact macroeconomic and inflationary conditions on
our business, including potential disruptions to our supply chain,
employees, operations, sales and overall market conditions; the
competitive pressures we face; risks associated with executing our
strategy; the distribution of our products and the delivery of our
services effectively; the development and transition of new
products and services and the enhancement of existing products and
services to meet customer needs and respond to emerging
technological trends; estimates and assumptions related to the cost
(including any possible disruption of our business) and the
anticipated benefits of the transformation and restructuring plans;
the outcome of any claims and disputes; the ability to meet stock
exchange continued listing standards; the possibility that the
Nasdaq may delist our common stock; risks related to our ability to
implement and maintain effective internal control over financial
reporting in the future; and other risks that are described herein,
including but not limited to the items discussed in “Risk Factors”
in our filings with the Securities and Exchange Commission (the
“SEC”), including our Form 10-K to be filed with the Securities and
Exchange Committee for the fiscal year ended March 31, 2024, and
any subsequent reports filed with the SEC. We do not intend to
update or alter our forward-looking statements, whether as a result
of new information, future events or otherwise, except as required
by applicable law or regulation.
QUANTUM CORPORATION
CONDENSED CONSOLIDATED BALANCE
SHEETS
(in thousands, except per
share amounts, unaudited)
|
| |
|
March 31,
|
|
2024
|
|
2023
|
|
|
|
Restated
|
Assets
|
|
|
|
Current assets:
|
|
|
|
Cash and cash equivalents
|
$
|
25,692
|
|
|
$
|
25,963
|
|
Restricted cash
|
|
168
|
|
|
|
212
|
|
Accounts receivable, net of allowance for
doubtful accounts of $22, $201 and $422, respectively
|
|
67,788
|
|
|
|
72,464
|
|
Manufacturing inventories
|
|
17,753
|
|
|
|
19,441
|
|
Service parts inventories
|
|
9,783
|
|
|
|
25,304
|
|
Prepaid expenses
|
|
2,186
|
|
|
|
4,158
|
|
Other current assets
|
|
8,414
|
|
|
|
5,513
|
|
Total current assets
|
|
131,784
|
|
|
|
153,055
|
|
|
|
|
|
Property and equipment, net
|
|
12,028
|
|
|
|
16,555
|
|
Intangible assets, net
|
|
1,669
|
|
|
|
4,941
|
|
Goodwill
|
|
12,969
|
|
|
|
12,969
|
|
Right-of-use assets, net
|
|
9,425
|
|
|
|
10,291
|
|
Other long-term assets
|
|
19,740
|
|
|
|
15,846
|
|
Total assets
|
$
|
187,615
|
|
|
$
|
213,657
|
|
Liabilities and Stockholders’
Deficit
|
|
|
|
Current liabilities:
|
|
|
|
Accounts payable
|
$
|
26,087
|
|
|
$
|
35,716
|
|
Accrued compensation
|
|
18,214
|
|
|
|
15,710
|
|
Deferred revenue, current portion
|
|
78,511
|
|
|
|
79,807
|
|
Term debt, current portion
|
|
82,496
|
|
|
|
5,000
|
|
Revolving credit facility
|
|
26,604
|
|
|
|
16,750
|
|
Warrant liabilities
|
|
4,046
|
|
|
|
7,989
|
|
Other accrued liabilities
|
|
13,986
|
|
|
|
13,666
|
|
Total current liabilities
|
|
249,944
|
|
|
|
157,888
|
|
Deferred revenue, net of current
portion
|
|
38,176
|
|
|
|
35,495
|
|
Revolving credit facility
|
|
—
|
|
|
|
16,750
|
|
Term debt, net of current portion
|
|
—
|
|
|
|
66,354
|
|
Operating lease liabilities
|
|
9,621
|
|
|
|
10,169
|
|
Other long-term liabilities
|
|
11,372
|
|
|
|
11,370
|
|
Total liabilities
|
|
309,113
|
|
|
|
298,026
|
|
|
|
|
|
Stockholders’ deficit
|
|
|
|
Preferred stock:
|
|
|
|
Preferred stock, 20,000 shares authorized;
no shares issued as of March 31, 2024, 2023 and 2022,
respectively
|
|
—
|
|
|
|
—
|
|
Common stock:
|
|
|
|
Common stock, $0.01 par value; 225,000
shares authorized; 95,850, 93,574 and 60,433 shares issued and
outstanding at March 31, 2024, 2023 and 2022, respectively
|
|
959
|
|
|
|
936
|
|
Additional paid-in capital
|
|
707,116
|
|
|
|
702,370
|
|
Accumulated deficit
|
|
(827,380
|
)
|
|
|
(786,094
|
)
|
Accumulated other comprehensive loss
|
|
(2,193
|
)
|
|
|
(1,581
|
)
|
Total stockholders' deficit
|
|
(121,498
|
)
|
|
|
(84,369
|
)
|
Total liabilities and stockholders'
deficit
|
$
|
187,615
|
|
|
$
|
213,657
|
|
QUANTUM CORPORATION
CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except per
share amounts, unaudited)
|
| |
|
Year Ended March 31,
|
|
2024
|
|
2023
|
|
|
|
Restated
|
Revenue
|
|
|
|
Product
|
$
|
174,879
|
|
|
$
|
274,854
|
|
Service and subscription
|
|
126,590
|
|
|
|
133,518
|
|
Royalty
|
|
10,131
|
|
|
|
13,705
|
|
Total revenue
|
|
311,600
|
|
|
|
422,077
|
|
Cost of revenue
|
|
|
|
Product
|
|
136,419
|
|
|
|
220,031
|
|
Service and subscription
|
|
50,292
|
|
|
|
58,782
|
|
Total cost of revenue
|
|
186,711
|
|
|
|
278,813
|
|
Gross profit
|
|
124,889
|
|
|
|
143,264
|
|
Operating expenses
|
|
|
|
Sales and marketing
|
|
60,893
|
|
|
|
66,034
|
|
General and administrative
|
|
51,547
|
|
|
|
47,752
|
|
Research and development
|
|
38,046
|
|
|
|
44,555
|
|
Restructuring charges
|
|
3,280
|
|
|
|
1,605
|
|
Total operating expenses
|
|
153,766
|
|
|
|
159,946
|
|
Loss from operations
|
|
(28,877
|
)
|
|
|
(16,682
|
)
|
Other income (expense), net
|
|
(1,746
|
)
|
|
|
1,956
|
|
Interest expense
|
|
(15,089
|
)
|
|
|
(10,560
|
)
|
Change in fair value of warrant
liability
|
|
5,137
|
|
|
|
10,250
|
|
Loss on debt extinguishment, net
|
|
—
|
|
|
|
(1,392
|
)
|
Net loss before income taxes
|
|
(40,575
|
)
|
|
|
(16,428
|
)
|
Income tax provision
|
|
711
|
|
|
|
1,940
|
|
Net loss
|
$
|
(41,286
|
)
|
|
$
|
(18,368
|
)
|
|
|
|
|
Net loss per share - basic
|
$
|
(0.43
|
)
|
|
$
|
(0.20
|
)
|
Net loss per share - diluted
|
$
|
(0.43
|
)
|
|
$
|
(0.28
|
)
|
Weighted average shares - basic
|
|
95,087
|
|
|
|
90,348
|
|
Weighted average shares - diluted
|
|
95,087
|
|
|
|
91,188
|
|
QUANTUM CORPORATION
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS
(in thousands,
unaudited)
|
| |
|
Year Ended March 31,
|
|
2024
|
|
2023
|
|
|
|
Restated
|
Operating activities
|
|
|
|
Net loss
|
$
|
(41,286
|
)
|
|
$
|
(18,368
|
)
|
Adjustments to reconcile net income (loss)
to net cash used in operating activities:
|
|
|
|
Depreciation and amortization
|
|
9,313
|
|
|
|
10,118
|
|
Amortization of debt issuance costs
|
|
2,735
|
|
|
|
1,624
|
|
Long-term debt related costs
|
|
—
|
|
|
|
992
|
|
Provision for manufacturing and service
inventories
|
|
6,490
|
|
|
|
18,052
|
|
Stock-based compensation
|
|
4,721
|
|
|
|
10,750
|
|
Change in fair value of warrant
liabilities
|
|
(3,943
|
)
|
|
|
(10,250
|
)
|
Other non-cash
|
|
3,304
|
|
|
|
(2,067
|
)
|
Changes in assets and liabilities, net of
effect of acquisitions:
|
|
|
|
Accounts receivable
|
|
4,846
|
|
|
|
(2,966
|
)
|
Manufacturing inventories
|
|
(1,396
|
)
|
|
|
(1,839
|
)
|
Service parts inventories
|
|
11,852
|
|
|
|
(3,503
|
)
|
Accounts payable
|
|
(11,193
|
)
|
|
|
1,158
|
|
Prepaid expenses
|
|
1,971
|
|
|
|
3,695
|
|
Deferred revenue
|
|
1,386
|
|
|
|
(11,611
|
)
|
Accrued compensation
|
|
2,504
|
|
|
|
(431
|
)
|
Other assets
|
|
(2,197
|
)
|
|
|
(1,270
|
)
|
Other liabilities
|
|
737
|
|
|
|
1,022
|
|
Net cash used in operating activities
|
|
(10,156
|
)
|
|
|
(4,894
|
)
|
Investing activities
|
|
|
|
Purchases of property and equipment
|
|
(5,869
|
)
|
|
|
(12,581
|
)
|
Business acquisitions
|
|
—
|
|
|
|
(3,020
|
)
|
Net cash used in investing activities
|
|
(5,869
|
)
|
|
|
(15,601
|
)
|
Financing activities
|
|
|
|
Borrowings of long-term debt, net of debt
issuance costs
|
|
12,541
|
|
|
|
—
|
|
Repayments of long-term debt
|
|
(5,747
|
)
|
|
|
(24,596
|
)
|
Borrowings of credit facility
|
|
421,623
|
|
|
|
497,280
|
|
Repayments of credit facility
|
|
(412,704
|
)
|
|
|
(498,665
|
)
|
Proceeds from issuance of common stock
|
|
—
|
|
|
|
67,146
|
|
Net cash provided by financing
activities
|
|
15,713
|
|
|
|
41,165
|
|
Effect of exchange rate changes on cash
and cash equivalents
|
|
(3
|
)
|
|
|
12
|
|
Net change in cash, cash equivalents, and
restricted cash
|
|
(315
|
)
|
|
|
20,682
|
|
Cash, cash equivalents, and restricted
cash at beginning of period
|
|
26,175
|
|
|
|
5,493
|
|
Cash, cash equivalents, and restricted
cash at end of period
|
$
|
25,860
|
|
|
$
|
26,175
|
|
Supplemental disclosure of cash flow
information
|
|
|
|
Cash paid for interest
|
$
|
12,314
|
|
|
$
|
8,701
|
|
Cash paid for income taxes, net of
refunds
|
$
|
1,776
|
|
|
$
|
1,418
|
|
Non-cash transactions
|
|
|
|
Purchases of property and equipment
included in accounts payable
|
$
|
661
|
|
|
$
|
1,049
|
|
Transfer of manufacturing inventory to
services inventory
|
$
|
341
|
|
|
$
|
4,045
|
|
Transfer of manufacturing inventory to
property and equipment
|
$
|
264
|
|
|
$
|
343
|
|
Paid-in-kind interest
|
$
|
2,314
|
|
|
$
|
319
|
|
The following table provides a
reconciliation of cash, cash equivalents and restricted cash
reported within the consolidated balance sheets that sum to the
total of the same such amounts shown in the statement of cash
flows:
|
Cash and cash equivalents
|
$
|
25,692
|
|
|
$
|
25,963
|
|
Restricted cash, current
|
|
168
|
|
|
|
212
|
|
Total cash, cash equivalents and
restricted cash at the end of period
|
$
|
25,860
|
|
|
$
|
26,175
|
|
NON-GAAP FINANCIAL MEASURES
To provide investors with additional information regarding our
financial results, we have presented certain non-GAAP financial
measures in this press release, including non-GAAP adjusted net
loss, adjusted EBITDA, non-GAAP gross profit and non-GAAP
operational expenses.
Adjusted EBITDA is a non-GAAP financial measure defined by us as
net loss before interest expense, net, provision for income taxes,
depreciation and amortization expense, stock-based compensation
expense, restructuring charges, and other non-recurring
expenses.
“GAAP net loss” as referred to in this press release represents
“Net loss attributable to common stockholders”. Non-GAAP adjusted
net income (loss) is a non-GAAP financial measure defined by us as
net loss before restructuring charges, stock-based compensation
expense, and other non-recurring (income) expenses. We calculate
adjusted net income (Loss) per basic and diluted share using the
above-referenced definition of adjusted net income (Loss).
We have provided below reconciliations of adjusted EBITDA to
adjusted net income (loss), non-GAAP gross profit and non-GAAP
operational expenses, to the most directly comparable U.S. GAAP
financial measures. We have presented adjusted EBITDA because it is
a key measure used by our management and the board of directors to
understand and evaluate our core operating performance and trends,
to prepare and approve our annual budget and to develop short and
long-term operating plans. In particular, we believe that the
exclusion of the amounts eliminated in calculating adjusted EBITDA
can provide a useful measure for period-to-period comparisons of
our core business performance. For example, in the quarter ended
September 30, 2022, we have excluded a large inventory reserve
provision caused by global supply chain disruptions since the start
of the pandemic and the longer associated lead times that resulted
in older generation products being displaced by next-generation
solutions. We do not believe an inventory adjustment of this
magnitude is reasonably likely to reoccur in the foreseeable future
and do not believe it is indicative of our ongoing operations;
accordingly, we have excluded its impact from our non-GAAP results.
We believe adjusted net income (loss) and adjusted net income
(loss) per basic and diluted share serve as appropriate measures to
be used in evaluating the performance of our business and help our
investors better compare our operating performance over multiple
periods. Accordingly, we believe that the use of non-GAAP financial
measures provide useful information to investors and others in
understanding and evaluating our operating results in the same
manner as our management and our board of directors.
Our use of non-GAAP financial measures have limitations as
analytical tools, and you should not consider them in isolation or
as a substitute for analysis of our financial results as reported
under U.S. GAAP. Some of these limitations are as follows:
- Although depreciation and amortization expense are non-cash
charges, the assets being depreciated and amortized may have to be
replaced in the future, and adjusted EBITDA does not reflect cash
capital expenditure requirements for such replacements or for new
capital expenditure requirements;
- Adjusted EBITDA does not reflect: (1) interest and tax payments
that may represent a reduction in cash available to us; (2) capital
expenditures, future requirements for capital expenditures or
contractual commitments; (3) changes in, or cash requirements for,
working capital needs; (4) the potentially dilutive impact of
stock-based compensation expense; (5) potential future costs
related to our long-term debt; (6) potential future restructuring
expenses; (7) potential future costs related to business
acquisitions; (8) gain (loss) on debt extinguishment, (9) and
acquisition-related amortization of intangibles assets from
business combinations, (10) fair market adjustments related to the
Company’s warrants, or (11) manufacturing inventory
provisions.
- Adjusted net income (loss) does not reflect: (1) potential
future restructuring activities; (2) the potentially dilutive
impact of stock-based compensation expense; (3) potential future
costs related to our long-term debt; (4) potential future costs
related to business acquisitions; (5) gain (loss) on debt
extinguishment; (6) acquisition-related amortization of intangibles
assets from business combinations; (7) fair market adjustments
related to the Company’s warrants; or (8) manufacturing inventory
provisions.
Other companies, including companies in our industry, may
calculate non-GAAP financial measures differently, which reduces
its usefulness as a comparative measure. Because of these and other
limitations, you should consider adjusted EBITDA and adjusted net
income (loss) along with other U.S. GAAP-based financial
performance measures, including various cash flow metrics and our
U.S. GAAP financial results.
In addition, this press release includes non-GAAP adjusted
earnings or net loss per share and adjusted EBITDA, each a non-GAAP
measure used to describe our expected performance. We have not
presented a reconciliation of these non-GAAP measures to our most
comparable GAAP financial measures, because the reconciliation
could not be prepared without unreasonable effort. The information
necessary to prepare the reconciliations is not available on a
forward-looking basis and cannot be accurately predicted. The
unavailable information could have a significant impact on the
calculation of the comparable GAAP financial measure.
The tables below reconcile the non-GAAP financial measures of
adjusted EBITDA, net income, diluted EPS, operating expenses and
gross margin with the most directly comparable GAAP financial
measures (in thousands, unaudited).
Adjusted EBITDA
|
Year Ended March 31,
|
(in thousands)
|
2024
|
|
2023
|
|
|
|
Restated
|
Net loss
|
$
|
(41,286
|
)
|
|
$
|
(18,368
|
)
|
Interest expense, net
|
|
15,396
|
|
|
|
10,560
|
|
Provision for income taxes
|
|
711
|
|
|
|
1,940
|
|
Depreciation expense
|
|
6,103
|
|
|
|
5,475
|
|
Stock-based compensation expense
|
|
4,721
|
|
|
|
10,750
|
|
Restructuring charges
|
|
4,019
|
|
|
|
2,178
|
|
Loss on extinguishment of Senior Secured
Term Loan
|
|
—
|
|
|
|
1,392
|
|
Amortization of acquisition related
intangible assets
|
|
3,272
|
|
|
|
4,643
|
|
Acquisition and debt related costs
|
|
2,002
|
|
|
|
818
|
|
Non-recurring project costs
|
|
4,895
|
|
|
|
—
|
|
Fair value of warrants adjustments
|
|
(5,137
|
)
|
|
|
(10,250
|
)
|
Service & Manufacturing inventory
provision
|
|
—
|
|
|
|
12,004
|
|
Adjusted EBITDA
|
$
|
(5,304
|
)
|
|
$
|
21,142
|
|
Non-GAAP adjusted net income and net income (loss) per
share
|
Year Ended March 31,
|
(in thousands)
|
2024
|
|
2023
|
|
|
|
Restated
|
Net loss
|
$
|
(41,286
|
)
|
|
$
|
(18,368
|
)
|
Stock-based compensation expense
|
|
4,721
|
|
|
|
10,750
|
|
Restructuring charges
|
|
4,019
|
|
|
|
2,178
|
|
Loss on extinguishment of Senior Secured
Term Loan
|
|
—
|
|
|
|
1,392
|
|
Amortization of acquisition related
intangible assets
|
|
3,272
|
|
|
|
4,643
|
|
Acquisition and debt related costs
|
|
2,002
|
|
|
|
818
|
|
Non-recurring project costs
|
|
4,895
|
|
|
|
—
|
|
Fair value of warrant adjustments
|
|
(5,137
|
)
|
|
|
(10,250
|
)
|
Service & Manufacturing inventory
provision
|
|
—
|
|
|
|
12,004
|
|
Adjusted net income (loss)
|
$
|
(27,514
|
)
|
|
$
|
3,167
|
|
|
|
|
|
Adjusted net income (loss) per share –
basic
|
$
|
(0.29
|
)
|
|
$
|
0.04
|
|
Adjusted net income (loss) per share -
diluted
|
$
|
(0.29
|
)
|
|
$
|
0.03
|
|
Weighted average shares – basic
|
|
95,087
|
|
|
|
90,348
|
|
Weighted average shares - diluted
|
|
95,087
|
|
|
|
91,188
|
|
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240617465968/en/
Investor Relations Contacts:
Shelton Group
Leanne K. Sievers | Brett L. Perry
P: 214-272-0070
E: sheltonir@sheltongroup.com
Quantum (NASDAQ:QMCO)
Historical Stock Chart
From May 2024 to Jun 2024
Quantum (NASDAQ:QMCO)
Historical Stock Chart
From Jun 2023 to Jun 2024